午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

ChemicalBook Chinese Germany Japanese Korean

上海阿拉丁生化科技股份有限公司 Company Information
Company Name:    Shanghai Aladdin Biochemical Technology Co.,Ltd.
Tel:    400-6206333
Email:    anhua.mao@aladdin-e.com
Nationality:    China
WebSite:    www.aladdin-e.com/
Product List:    48458
459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485
Product List
Dehydroepiandrosterone sulfate 651-48-9
8-Azahypoxanthine 2683-90-1
Eculizumab (anti-Complement C5) 219685-50-4
Sirukumab (anti-IL-6) 1194585-53-9
Bimagrumab (anti-ACVR2B) 1356922-05-8
Ulocuplumab (anti-CXCR4) 1375830-34-4
Abelacimab(anti-Factor XI) 2098724-83-3
Tesnatilimab (anti-NKG2D) 2242758-08-1
Zansecimab (anti-ANGPT2) 2415205-37-5
Meropenem-d6 1133424-00-6
Ranibizumab (anti-VEGFA) 347396-82-1
2-(azetidin-1-yl)ethan-1-amine 795299-77-3
Enoblituzumab (anti-CD276) 1353485-38-7
Flanvotumab (anti-TYRP1) 1188277-05-5
Bermekimab (anti-IL-1a) 1401965-15-8
Inebilizumab (anti-CD19) 1299440-37-1
Prezalumab (anti-B7-H2) 1523164-68-2
Depatuxizumab mafodotin (anti-EGFR) 1585973-65-4
Tinurilimab (anti-CEACAM6) 2226224-30-0
Vandortuzumab (anti-STEAP1) 1557989-52-2
Galiximab (anti-CD80) 357613-77-5
Ethyl 2-oxo-4-phenylbutyrate 64920-29-2
Pascolizumab (anti-IL-4) 331243-22-2
Ocrelizumab (anti-CD20) 637334-45-3
Bis(hexamethylene)triamine 143-23-7
Ixekizumab (anti-CTLA-8) 1143503-69-8
Enokizumab (anti-IL-9) 909875-08-7
Concizumab (anti-TFPI) 1312299-39-0
Tarextumab (anti-NOTCH3) 1359940-55-8
Emibetuzumab (anti-MET) 1365287-97-3
Tesidolumab (anti-Complement C5) 1531594-08-7
Xentuzumab (anti-IGF1) 1417158-65-6
Lacnotuzumab (anti-M-CSF) 1831128-32-5
Ladiratuzumab (anti-SLC39A6) 1629760-28-6
Narsoplimab (anti-MASP2) 2108782-45-0
Belimumab (anti-TNFSF13B) 356547-88-1
IDO-IN-13 2291164-02-6
Benzyldiphenylphosphine 7650-91-1
Alizarin Yellow R sodium salt 1718-34-9
Eldelumab (anti-CXCL10) 946414-98-8
Tisotumab (anti-F3) 1418628-81-5
Vopratelimab (anti-ICOS) 2039148-04-2
Ragifilimab (anti-TNFRSF18) 2207590-51-8
Daclizumab (anti-IL2RA) 152923-56-3
Sonepcizumab (anti-Sphingosine-1-phosphate) 1031360-18-5
Rilotumumab (anti-HGF) 872514-65-3
Narnatumab (anti-RON) 1188275-92-4
Carotuximab (anti-CD105) 1268714-50-6
Brazikumab (anti-IL-23) 1610353-18-8
Ontamalimab (anti-MADCAM1) 2098790-40-8
Dostarlimab (anti-PD-1) 2022215-59-2
Avdoralimab (anti-C5AR1) 2226393-85-5
Datopotamab (anti-TROP2) 2267989-53-5
Denintuzumab (anti-CD19) 1630074-14-4
Mogamulizumab (anti-CCR4) 1159266-37-1
Rosmantuzumab (anti-RSPO3) 1684393-04-1
Ianalumab (anti-TNFRSF13C) 1929549-92-7
Quetmolimab (anti-CX3CL1) 2084037-83-0
Gemtuzumab (anti-CD33) 220578-59-6
Telazorlimab (anti-TNFRSF4) 2126777-87-3
Imazapic 104098-48-8
Guselkumab (anti-IL-23) 1350289-85-8
Labetuzumab govitecan (anti-CEACAM5) 1469876-18-3
Apamistamab (anti-PTPRC) 2097132-02-8
Sirtratumab (anti-SLITRK6) 1824663-82-2
Nadecnemab (anti-GFRA3) 2377679-19-9
Dysprosium(III) trifluoromethanesulfonate 139177-62-1
Efalizumab (anti-ITGAL) 214745-43-4
Elotuzumab (anti-SLAMF7) 915296-00-3
Oxelumab (anti-TNFSF4) 1186098-83-8
Seribantumab (anti-ERBB3) 1334296-12-6
Zagotenemab (anti-Tau) 2019133-28-7
Bexmarilimab (anti-STAB1) 2259301-27-2
Lemzoparlimab (anti-CD47) 2377483-71-9
Enfortumab (anti-NECTIN4) 1448664-46-7
KWAR23 (anti-SIRPg) 2243227-60-1
Lexatumumab (anti-TNFRSF10B) 845816-02-6
Bivatuzumab (anti-CD44v6) 214559-60-1
Urelumab (anti-TNFRSF9) 934823-49-1
Dinutuximab (anti-GD2) 1363687-32-4
Ravulizumab (anti-Complement C5) 1803171-55-2
Apelin 17 TFA 217082-57-0
Lumiliximab (anti-FceR2) 357613-86-6
Otilimab (anti-GM-CSF) 1638332-55-4
Fulranumab (anti-NGF) 902141-80-4
Vorsetuzumab (anti-CD70) 1165740-62-4
Vantictumab (anti-FZD) 1345009-45-1
Indusatumab (anti-GUCY2C) 1497400-26-6
Tamrintamab (anti-DPEP3) 2148325-59-9
Cinpanemab (anti-Alpha-synuclein) 2094516-02-4
Daxdilimab (anti-ILT7) 2245966-28-1
Idactamab (anti-SLC1A5) 2245205-37-0
Ponsegromab (anti-GDF15) 2368950-15-4
Gevokizumab (anti-IL-1b) 1129435-60-4
Itolizumab (anti-CD6) 1116433-11-4
Girentuximab (anti-CA9) 916138-87-9
Codrituzumab (anti-GPC3) 1365267-33-9
Vunakizumab (anti-IL-17a) 1792181-33-9
Imaprelimab (anti-CD146) 2014343-04-3
Serplulimab (anti-PDCD1) 2231029-82-4
459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485
Copyright 2007©  ChemicalBook. All rights reserved.